| human | Q5 |
| P1153 | Scopus author ID | 35476979600 |
| P108 | employer | Yale University | Q49112 |
| P800 | notable work | Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone | Q28646319 |
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q54624243 | "Glycated" osteocalcin in human and bovine bone. The effect of age. |
| Q71886583 | 24,25 Dihydroxyvitamin D supplementation corrects hyperparathyroidism and improves skeletal abnormalities in X-linked hypophosphatemic rickets--a clinical research center study |
| Q35832437 | A 7-day continuous infusion of PTH or PTHrP suppresses bone formation and uncouples bone turnover |
| Q56100872 | A Comparison of Parathyroid Hormone-Related Protein (1-36) and Parathyroid Hormone (1-34) on Markers of Bone Turnover and Bone Density in Postmenopausal Women: The PrOP Study |
| Q37213526 | A comparison of parathyroid hormone-related protein (1-36) and parathyroid hormone (1-34) on markers of bone turnover and bone density in postmenopausal women: the PrOP study |
| Q71773685 | A comparison of the effects of parathyroid hormone and parathyroid hormone-related protein on osteocalcin in the rat |
| Q36543437 | A reciprocal regulatory interaction between megakaryocytes, bone cells, and hematopoietic stem cells |
| Q33792057 | Adulthood obesity is positively associated with adipose tissue concentrations of vitamin K and inversely associated with circulating indicators of vitamin K status in men and women |
| Q35892387 | Age group and sex do not influence responses of vitamin K biomarkers to changes in dietary vitamin K. |
| Q45096570 | Associations between vitamin K biochemical measures and bone mineral density in men and women |
| Q60777498 | Basic science and clinical utility of biochemical markers of bone turnover--a Congress report |
| Q49294241 | Biomolecular regulation, composition and nanoarchitecture of bone mineral |
| Q38262674 | Bone as an endocrine organ relevant to diabetes |
| Q38263771 | Calcitonin administration in X-linked hypophosphatemia |
| Q46583439 | Calcium absorption, bone mass accumulation, and kinetics increase during early pubertal development in girls |
| Q74619307 | Changes in bone turnover in young women consuming different levels of dietary protein |
| Q54444192 | Changes in serum osteocalcin associated with parathyroid hormone infusion in X-linked hypophosphatemic rickets. |
| Q68823000 | Changing osteocalcin concentrations during pregnancy and lactation: implications for maternal mineral metabolism |
| Q71652194 | Circulating levels of interleukin-6 and tumor necrosis factor-alpha are elevated in primary hyperparathyroidism and correlate with markers of bone resorption--a clinical research center study |
| Q44203976 | Circulating levels of interleukin-6 soluble receptor predict rates of bone loss in patients with primary hyperparathyroidism. |
| Q34262497 | Circulating levels of soluble klotho and FGF23 in X-linked hypophosphatemia: circadian variance, effects of treatment, and relationship to parathyroid status |
| Q35112095 | Circulating uncarboxylated matrix gla protein is associated with vitamin K nutritional status, but not coronary artery calcium, in older adults |
| Q43813756 | Clearance of osteocalcin by peritoneal dialysis in children with end-stage renal disease |
| Q71010609 | Clinical evaluation of bone turnover by serum osteocalcin measurements in a hospital setting |
| Q34450703 | Continuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1,25(OH)2 vitamin D. |
| Q69873112 | Determination of osteocalcin in human serum: results with two kits compared with those by a well-characterized assay |
| Q41113879 | Development and validation of a radioimmunoassay for mouse osteocalcin: paradoxical response in the Hyp mouse |
| Q34131232 | Dietary and nondietary determinants of vitamin K biochemical measures in men and women |
| Q34468075 | Dilatational band formation in bone |
| Q77114111 | Dissociation of bone formation from resorption during 2-week treatment with human parathyroid hormone-related peptide-(1-36) in humans: potential as an anabolic therapy for osteoporosis |
| Q41330378 | Effect of high-dose vitamin D supplementation on radiographically detectable bone disease of very low birth weight infants |
| Q34130936 | Effect of paricalcitol on circulating parathyroid hormone in X-linked hypophosphatemia: a randomized, double-blind, placebo-controlled study |
| Q36536769 | Effect of vitamin K supplementation on bone loss in elderly men and women |
| Q36945258 | Effect of vitamin K supplementation on insulin resistance in older men and women |
| Q77291983 | Effects of a hydrogenated form of vitamin K on bone formation and resorption |
| Q47250734 | Effects of aluminum on rat bone cell populations |
| Q73640212 | Effects of calcitonin gene-related peptide on bone turnover in ovariectomized rats |
| Q44203969 | Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial |
| Q72464552 | Effects of strength training on bone mineral density: hormonal and bone turnover relationships |
| Q46568400 | Efficacy of high dose phylloquinone in correcting vitamin K deficiency in cystic fibrosis |
| Q68480841 | Estrogen deficiency in adolescents and young adults: impact on bone mineral content and effects of estrogen replacement therapy |
| Q36589402 | Evaluation of markers of bone turnover during lactation in African-Americans: a comparison with Caucasian lactation |
| Q36657486 | Expression of an estrogen receptor agonist in differentiating osteoblast cultures |
| Q61760408 | Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin |
| Q35692114 | Gamma-carboxylation and fragmentation of osteocalcin in human serum defined by mass spectrometry |
| Q37388026 | Gamma-carboxylation of osteocalcin and insulin resistance in older men and women |
| Q36290763 | Identification and characterization of glycation adducts on osteocalcin. |
| Q41182577 | Increased bone formation in osteocalcin-deficient mice. |
| Q33634310 | Increased bone volume and correction of HYP mouse hypophosphatemia in the Klotho/HYP mouse |
| Q39547377 | Influence of carboxylation on osteocalcin detection by mass spectrometry |
| Q39997540 | Investigating the mechanism for maintaining eucalcemia despite immobility and anuria in the hibernating American black bear (Ursus americanus). |
| Q42272866 | LIM kinase 1 deficient mice have reduced bone mass |
| Q33786830 | Lactation and bone turnover: a conundrum of marked bone loss in the setting of coupled bone turnover |
| Q35101774 | Lower uncarboxylated osteocalcin concentrations in children with prediabetes is associated with beta-cell function |
| Q35541088 | Matrix proteins |
| Q70985242 | Measurements of gamma-carboxyglutamate and circulating osteocalcin in normal children and adults |
| Q38312243 | Megakaryocyte-mediated inhibition of osteoclast development |
| Q28585601 | Megakaryocyte-osteoblast interaction revealed in mice deficient in transcription factors GATA-1 and NF-E2 |
| Q72036819 | Microsomal enzyme induction and gingival enlargement in subjects taking phenytoin |
| Q37513381 | NMR investigation of the role of osteocalcin and osteopontin at the organic-inorganic interface in bone |
| Q36357864 | Osteoblasts mediate the adverse effects of glucocorticoids on fuel metabolism. |
| Q35791548 | Osteocalcin Is Not Associated with the Risk of Type 2 Diabetes: Findings from the EPIC-NL Study |
| Q71826137 | Osteocalcin abnormalities in Hyp mice reflect altered genetic expression and are not due to altered clearance, affinity for mineral, or ambient phosphorus levels |
| Q68219857 | Osteocalcin and its message: relationship to bone histology in magnesium-deprived rats |
| Q28646319 | Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone |
| Q47433578 | Osteocalcin and osteopontin influence bone morphology and mechanical properties |
| Q36276003 | Osteocalcin carboxylation is not associated with body weight or percent fat changes during weight loss in post-menopausal women |
| Q74013197 | Osteocalcin production in primary osteoblast cultures derived from normal and Hyp mice |
| Q39625461 | Osteocalcin. Biochemical considerations and clinical applications |
| Q72403220 | Osteocalcin: Isolation, characterization, and detection |
| Q67840937 | Parameters of calcium metabolism during a pilot study of cyclosporin A in patients with symptomatic primary biliary cirrhosis |
| Q33738711 | Parathyroid hormone-related protein for the treatment of postmenopausal osteoporosis: defining the maximal tolerable dose |
| Q72646425 | Parenteral pamidronate prevents thyroid hormone-induced bone loss in rats |
| Q68241222 | Partial characterization of rat marrow stromal cells |
| Q46631338 | Patterns of osteocalcin and bone specific alkaline phosphatase by age, gender, and race or ethnicity |
| Q70551274 | Phenytoin and bone metabolism |
| Q71305327 | Phenytoin therapy and hemorrhagic disease |
| Q44046344 | Physiologic regulators of bone turnover in young women with anorexia nervosa. |
| Q78888570 | Positive linear growth and bone responses to growth hormone treatment in children with types III and IV osteogenesis imperfecta: high predictive value of the carboxyterminal propeptide of type I procollagen |
| Q73383291 | Posttransplant bone disease: evidence for a high bone resorption state |
| Q47258367 | Presence of osteocalcin and related higher molecular weight 4-carboxyglutamic acid-containing proteins in developing bone |
| Q46269234 | Prevalence of low bone mass and deficiencies of vitamins D and K in pediatric patients with cystic fibrosis from 3 Canadian centers |
| Q39413743 | Reducing Undercarboxylated Osteocalcin With Vitamin K Supplementation Does Not Promote Lean Tissue Loss or Fat Gain Over 3 Years in Older Women and Men: A Randomized Controlled Trial |
| Q34131402 | Relationships among vitamin D levels, parathyroid hormone, and calcium absorption in young adolescents |
| Q79809297 | Repetitive exposure to TGF-beta suppresses TGF-beta type I receptor expression by differentiated osteoblasts |
| Q78231940 | Response of vitamin K status to different intakes and sources of phylloquinone-rich foods: comparison of younger and older adults |
| Q64900205 | Safety and tolerability of subcutaneous PTHrP(1-36) in healthy human volunteers: a dose escalation study. |
| Q68814594 | Serum osteocalcin and total body calcium in normal pre- and postmenopausal women and postmenopausal osteoporotic patients |
| Q69868501 | Serum osteocalcin concentrations in children with metabolic bone disease |
| Q70984074 | Serum osteocalcin in the treatment of inherited rickets with 1,25-dihydroxyvitamin D3 |
| Q78945716 | Short-term, high-dose parathyroid hormone-related protein as a skeletal anabolic agent for the treatment of postmenopausal osteoporosis |
| Q47332419 | Skeletal effects of sodium fluoride during hypokinesia |
| Q54241636 | Strength training increases regional bone mineral density and bone remodeling in middle-aged and older men. |
| Q70660352 | The calciotropic hormone response to changes in serum calcium during exercise in female long distance runners |
| Q81196333 | The effect of aging on the skeletal response to intermittent treatment with parathyroid hormone |
| Q33735499 | The effect of dietary protein on intestinal calcium absorption in rats. |
| Q34026190 | The effects of GATA-1 and NF-E2 deficiency on bone biomechanical, biochemical, and mineral properties |
| Q70130248 | The influence of ibuprofen on fracture repair: biomechanical, biochemical, histologic, and histomorphometric parameters in rats |
| Q41114125 | The osteocalcin propeptide is not secreted in vivo or in vitro |
| Q46590456 | The presence of both an energy deficiency and estrogen deficiency exacerbate alterations of bone metabolism in exercising women |
| Q35636353 | The role of osteocalcin in human glucose metabolism: marker or mediator? |
| Q83221974 | The ternary IGF complex influences postnatal bone acquisition and the skeletal response to intermittent parathyroid hormone |
| Q72921668 | Therapy with parenteral pamidronate prevents thyroid hormone-induced bone turnover in humans |
| Q70995812 | Urinary gamma-carboxyglutamic acid and serum osteocalcin as bone markers: studies in osteoporosis and Paget's disease |
| Q39990602 | Vitamin K and bone: past, present, and future |
| Q52235837 | Vitamin K status and bone health: an analysis of methods for determination of undercarboxylated osteocalcin. |
| Q36868914 | Vitamin K, circulating cytokines, and bone mineral density in older men and women |
| Q36828712 | Vitamin K-dependent carboxylation of osteocalcin: friend or foe? |
| Q70993617 | Vitamin K-dependent proteins and anticonvulsant medication |
| Q67000097 | gamma-Carboxyglutamate analysis by selective anion exchange elution and fluorescent detection |
| Q69926294 | gamma-Carboxyglutamic acid |
Search more.